ConductScience.org, home

Paper799565

Medical Research Council's Treatment Trial for mild hypertension: an interim report.

Miall WE and 2 others. Clin Sci Mol Med Suppl, 1976. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Medical Research Council's Treatment Trial for mild hypertension: an interim report. Papers, record 799565. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/799565

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Medical Research Council's Treatment Trial for mild hypertension: an interim report.
PubMed
Journal
Clin Sci Mol Med Suppl
PubMed
Year
1976
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.23
iCite
Revised in PubMed
2026-01-28
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Miall WEW E
2Brennan PJP J
3Mann AHA H

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HypertensionMajor topic
Adult
Bendroflumethiazide
Clinical Trials as Topic
Female
Humans
Male
Middle Aged
Neurotic Disorders
Propranolol
United Kingdom

Source PubMed

Download CSV of topics

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
41925078Pharmacotherapy for mild hypertension.Cochrane Database Syst Rev2026https://conductscience.org/library/papers/41925078PubMed
40990196Pharmacotherapy for mild hypertension.Cochrane Database Syst Rev2025https://conductscience.org/library/papers/40990196PubMed
30312512The effect of indapamide vs. bendroflumethiazide for primary hypertension: a systematic review.Br J Clin Pharmacol2019https://conductscience.org/library/papers/30312512PubMed
29667175First-line drugs for hypertension.Cochrane Database Syst Rev2018https://conductscience.org/library/papers/29667175PubMed
28813123Pharmacotherapy for hypertension in adults aged 18 to 59 years.Cochrane Database Syst Rev2017https://conductscience.org/library/papers/28813123PubMed
22895954Pharmacotherapy for mild hypertension.Cochrane Database Syst Rev2012https://conductscience.org/library/papers/22895954PubMed
387375Mild hypertension: to treat or not to treat?Drugs1979https://conductscience.org/library/papers/387375PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/799565

GET https://conductscience.org/api/papers/v1/799565/authors